Marlene Wullt

1.8k total citations
24 papers, 1.4k citations indexed

About

Marlene Wullt is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Marlene Wullt has authored 24 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 10 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in Marlene Wullt's work include Clostridium difficile and Clostridium perfringens research (15 papers), Viral gastroenteritis research and epidemiology (7 papers) and Microscopic Colitis (7 papers). Marlene Wullt is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (15 papers), Viral gastroenteritis research and epidemiology (7 papers) and Microscopic Colitis (7 papers). Marlene Wullt collaborates with scholars based in Sweden, Germany and Denmark. Marlene Wullt's co-authors include Inga Odenholt, Marie-Louise Johansson Hagslätt, Mats Walder, Thomas Åkerlund, Torbjörn Norén, Helena Janols, Anders Bredberg, Karin Leandersson, Caroline Bergenfelz and Lars Burman and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Journal of Clinical Microbiology.

In The Last Decade

Marlene Wullt

24 papers receiving 1.4k citations

Peers

Countries citing papers authored by Marlene Wullt

Since Specialization

Citations

This map shows the geographic impact of Marlene Wullt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlene Wullt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlene Wullt more than expected).

Fields of papers citing papers by Marlene Wullt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlene Wullt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlene Wullt. The network helps show where Marlene Wullt may publish in the future.

Co-authorship network of co-authors of Marlene Wullt

This figure shows the co-authorship network connecting the top 25 collaborators of Marlene Wullt. A scholar is included among the top collaborators of Marlene Wullt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlene Wullt. Marlene Wullt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Humoral response to Clostridium difficile in inflammatory bowel disease, including correlation with immunomodulatory treatment 2018 ·JGH Open ·Gunnel Henriksson, (unknown), Marlene Wullt, E Lyrenäs, Ulf Hindorf, Björn Ohlsson, Olof Grip	4
2	Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients 2015 ·PLoS ONE ·Caroline Bergenfelz, Anna-Maria Larsson, Kristoffer von Stedingk, Sofia K. Gruvberger-Saal, Kristina Aaltonen, Sara Jansson, Helena Jernström, Helena Janols, Marlene Wullt, Anders Bredberg, Lisa Rydén, Karin Leandersson	115
3	Heterogeneity among septic shock patients in a set of immunoregulatory markers 2013 ·European Journal of Clinical Microbiology & Infectious Diseases ·Helena Janols, Marlene Wullt, Caroline Bergenfelz, Sven Björnsson, (unknown), Sabina Janciauskiene, Karin Leandersson, Anders Bredberg	13
4	Ribotyping of Clostridium difficile strains associated with nosocomial transmission and relapses in a Swedish County 2012 ·Apmis ·(unknown), Marlene Wullt, Sture Löfgren, (unknown), (unknown), Andreas Matussek	12
5	Wnt5a Induces a Tolerogenic Phenotype of Macrophages in Sepsis and Breast Cancer Patients 2012 ·The Journal of Immunology ·Caroline Bergenfelz, (unknown), Elin Ekström, Karin Jirström, Helena Janols, Marlene Wullt, Anders Bredberg, Karin Leandersson	104
6	IgG Antibody Response to Toxins A and B in Patients with Clostridium difficile Infection 2012 ·Clinical and Vaccine Immunology ·Marlene Wullt, Torbjörn Norén, Åsa Ljungh, Thomas Åkerlund	29
7	A Head-to-Head Comparison of Hydrogen Peroxide Vapor and Aerosol Room Decontamination Systems 2011 ·Infection Control and Hospital Epidemiology ·(unknown), Peter Lanbeck, Marlene Wullt, Mats Walder	43
8	Multidrug resistance in European Clostridium difficile clinical isolates 2011 ·Journal of Antimicrobial Chemotherapy ·Patrizia Spigaglia, Fabrizio Barbanti, Paola Mastrantonio, (unknown), G Ackermann, Carlo Balmelli, Frédéric Barbut, Emilio Bouza, J S Brazier, Michel Delmée, Denise Drudy, Ed J. Kuijper, (unknown), Edit Nagy, Hanna Pituch, Ian R. Poxton, Maja Rupnik, Marlene Wullt, M. Yücesoy	149
9	Lymphocyte and monocyte flow cytometry immunophenotyping as a diagnostic tool in uncharacteristic inflammatory disorders 2010 ·BMC Infectious Diseases ·Helena Janols, Anders Bredberg, (unknown), Sabina Janciauskiene, Olof Grip, Marlene Wullt	17
10	Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics 2008 ·Acta Anaesthesiologica Scandinavica ·Bengt Klarin, Marlene Wullt, Ingrid Palmquist, G. Molin, Anne Larsson, Bengt Jeppsson	69
11	Increased Sporulation Rate of Epidemic Clostridium difficile Type 027/NAP1 2008 ·Journal of Clinical Microbiology ·Thomas Åkerlund, Ingela Persson, Magnus Unemo, Torbjörn Norén, Bo Svenungsson, Marlene Wullt, Lars Burman	180
12	Pharmacodynamic Studies of Vancomycin, Metronidazole and Fusidic Acid against <i>Clostridium difficile</i> 2007 ·Chemotherapy ·Inga Odenholt, Mats Walder, Marlene Wullt	27
13	Mutations in fusA Associated with Posttherapy Fusidic Acid Resistance in Clostridium difficile 2007 ·Antimicrobial Agents and Chemotherapy ·Torbjörn Norén, Thomas Åkerlund, Marlene Wullt, Lars Burman, Magnus Unemo	19
14	Lactobacillus plantarum 299v Enhances the Concentrations of Fecal Short-Chain Fatty Acids in Patients with Recurrent Clostridium difficile-Associated Diarrhea 2007 ·Digestive Diseases and Sciences ·Marlene Wullt, Marie-Louise Johansson Hagslätt, Inga Odenholt, Anna Berggren	53
15	Frequent Emergence of Resistance in Clostridium difficile during Treatment of C. difficile -Associated Diarrhea with Fusidic Acid 2006 ·Antimicrobial Agents and Chemotherapy ·Torbjörn Norén, Marlene Wullt, Thomas Åkerlund, Erik Bäck, Inga Odenholt, Lars Burman	44
16	A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea 2004 ·Journal of Antimicrobial Chemotherapy ·Marlene Wullt	81
17	Comparison of AP-PCR typing and PCR-ribotyping for estimation of nosocomial transmission of Clostridium difficile 2003 ·Journal of Hospital Infection ·Marlene Wullt, Lars Burman, Martin Laurell, Thomas Åkerlund	14
18	Activity of Three Disinfectants and Acidified Nitrite AgainstClostridium difficileSpores 2003 ·Infection Control and Hospital Epidemiology ·Marlene Wullt, Inga Odenholt, Mats Walder	65
19	Lactobacillus plantarum 299v for the Treatment of Recurrent Clostridium difficile-associated Diarrhoea: A Double-blind, Placebo-controlled Trial 2003 ·Scandinavian Journal of Infectious Diseases ·Marlene Wullt, Marie-Louise Johansson Hagslätt, Inga Odenholt	170
20	Low prevalence of nosocomial Clostridium difficile transmission, as determined by comparison of arbitrarily primed PCR and epidemiological data 1999 ·Journal of Hospital Infection ·Marlene Wullt, Martin Laurell	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact